Ethyl biscoumacetate

• Description :

  Ethyl biscoumacetate is an anticoagulant and vitamin K antagonist. Ethyl biscoumacetate can be used in the research of experimental venous thrombosis[1][2][3].

• UNSPSC :

  12352005

• Hazard Statement :

  H315-H319-H320

• Target :

  Biochemical Assay Reagents

• Related Pathways :

  Others

• Field of Research :

  Cardiovascular Disease

• Smiles :

  O=C(OCC)C(C1=C(O)C2=CC=CC=C2OC1=O)C3=C(O)C4=CC=CC=C4OC3=O

• Molecular Formula :

  C22H16O8

• Molecular Weight :

  408.36

• Precautions :

  P264-P280-P302+P352-P305+P351+P338-P362

• References & Citations :

  [1]CHATTERJEA JB, et al. Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate. Br Med J. 1954 Oct 2;2 (4891) :790-2. |[2]Sharaev P N, et al. Aortic glycosaminoglycans in avitaminosis. Bulletin of Experimental Biology and Medicine, 1979, 88 (1) : 733-734. |[3]JEWELL P, et al. Heparin and ethyl biscoum-acetate in prevention of experimental venous thrombosis. Br Med J. 1954 May 1;1 (4869) :1013-6.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [548-00-5]